The availability of other sources for comparable products or services
“Whether the proposed transaction is on terms comparable to terms available to an unrelated third party or employees generally Whether the transaction would impair the judgment of a director or executive officer to act in our best interest”
Read it in the proxyopen_in_new
Review and approval of related party transactions
“We review all relationships and transactions involving the Company and our directors, director nominees, executive officers, 5% stockholders and each of their immediate family members that may involve a direct or indirect material interest by such persons. Our Code of Conduct and Ethics instructs our directors, officers and employees to report the facts and circumstances of any such transaction or potential transaction to our General Counsel or our Audit Committee. Our board of directors has adopted a policy regarding the review of potential related party transactions. Under this policy, our General Counsel will review the facts and circumstances of any covered transaction. If our General Counsel determines that the transaction involves a related party transaction and the amount involved does not equal or exceed $120,000, our General Counsel will approve or disapprove the transaction. If our General Counsel determines that the transaction involves a related party transaction and the amount involved equals or exceeds $120,000, our General Counsel will refer the transaction to our Audit Committee for consideration. In reviewing, approving or ratifying a related party transaction, our General Counsel (for transactions below $120,000) or the Audit Committee or its Chair (for transactions exceeding $120,000) considers factors as they consider appropriate, including but not limited to the factors in the box to the right.”
Read it in the proxyopen_in_new
Related party transactions
“As required under SEC rules, transactions since the beginning of our last fiscal year, or any currently proposed transaction, in which we are a participant and which involve amounts exceeding $120,000, and in which any related person had or will have a direct or indirect material interest are disclosed in our Proxy Statement. In addition to the procedures set forth above, each year we require our executive officers, directors and director nominees to submit a routine questionnaire seeking confirmation of, among other things, any transactions with the Company in which such person, or their family members, may have an interest. Other than as set forth below, there were no such related person transactions since January 1, 2025.”
Read it in the proxyopen_in_new
Related party transactions
“The Company entered into a Stock Purchase Agreement, dated as of December 15, 2025, with Orogen Echo LLC (“Orogen”), an affiliate of The Orogen Group LLC, pursuant to which the Company privately repurchased 1,551,970 shares of the Company’s common stock from Orogen for an aggregate purchase price of $63.4 million based on a purchase price per share of $40.834, which was the volume weighted average price over the 5 days prior to settlement. The terms of the contract with Orogen were, in the Company’s opinion, no less favorable than the Company would have been able to negotiate with an unrelated party, and the transaction was approved by the Audit Committee. After considering the facts and circumstances regarding the relationship, our board of directors has determined that the stock repurchase from Orogen did not and does not impair Mr. Pandit’s independence under applicable Nasdaq standards and federal securities laws.”
Read it in the proxyopen_in_new